YCG LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,157
Closed -$357K 38
2017
Q1
$357K Sell
2,157
-50,479
-96% -$8.03M 0.1% 34
2016
Q4
$7.57M Sell
52,636
-10,259
-16% -$1.37M 2.26% 19
2016
Q3
$7.88M Buy
62,895
+2,962
+5% +$382K 2.42% 19
2016
Q2
$7.87M Buy
59,933
+2,620
+5% +$358K 2.52% 19
2016
Q1
$7.97M Sell
57,313
-746
-1% -$99.7K 2.51% 18
2015
Q4
$8.1M Buy
58,059
+2,318
+4% +$319K 2.25% 20
2015
Q3
$7.8M Buy
55,741
+374
+0.7% +$56.2K 2.36% 19
2015
Q2
$9.09M Sell
55,367
-1,181
-2% -$189K 2.7% 16
2015
Q1
$8.73M Buy
56,548
+19,029
+51% +$2.71M 2.62% 17
2014
Q4
$7.23M Sell
37,519
-18,295
-33% -$2.26M 2.27% 17
2014
Q3
$6.68M Sell
55,814
-62
-0.1% -$7.11K 2.33% 17
2014
Q2
$6.01M Buy
55,876
+531
+1% +$54.7K 2.2% 18
2014
Q1
$5.51M Sell
55,345
-1,151
-2% -$104K 2.25% 17
2013
Q4
$5.22M Sell
56,496
-1,397
-2% -$124K 2.19% 17
2013
Q3
$4.88M Buy
57,893
+74
+0.1% +$6.34K 2.2% 18
2013
Q2
$4.73M Buy
+57,819
New +$4.33M 2.18% 19

Other funds holding ELV

YCG LLC's ELV Position: Q2 2017 in Review

YCG LLC sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 2,157 shares — an estimated $357K sold.

YCG LLC first reported a position in ELV in Q2 2013 and held it in 16 quarters. The position peaked at $9.09M in Q2 2015. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • YCG LLC reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • YCG LLC sold 2,157 Elevance Health shares in Q2 2017, an estimated $357K.
  • YCG LLC first reported a position in Elevance Health in Q2 2013 and held it in 16 quarters.
  • YCG LLC's Elevance Health position peaked at $9.09M in Q2 2015.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on YCG LLC's 13F filing for Q2 2017, filed 17 Jul 2017.